[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363615-105":59,"doc-detail-363615-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-human-breast-microbiome-from-homeostasis-to-malignancy-mechanistic-insights-and-therapeutic-perspectives","The Human Breast Microbiome - From Homeostasis to Malignancy, Mechanistic Insights and Therapeutic Perspectives","","Although human mammary glands were traditionally considered sterile, accumulated evidence supports distinct microbial communities in breast tissue, potentially introduced via retrograde nipple flow or through hematogenous or lymphatic translocation. Comparative studies distinguish microbiota in healthy versus diseased breasts, including differences across breast cancer subtypes and versus adjacent normal tissue. This review integrates evidence on breast microbiome composition, developmental shaping factors, and inflammatory and malignant alterations, emphasizing mechanistic, methodological, and future therapeutic directions. It highlights unresolved barriers such as low-biomass contamination, inter-study variability, limited longitudinal data, and incomplete causal understanding, which are essential for microbiome-based diagnostics and therapy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-human-breast-microbiome-from-homeostasis-to-malignancy-mechanistic-insights-and-therapeutic-perspectives/363615/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-human-breast-microbiome-from-homeostasis-to-malignancy-mechanistic-insights-and-therapeutic-perspectives/363615.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How can microbes reach breast tissue according to the review?","Question",{"text":113,"@type":114},"The review notes possible routes including retrograde nipple flow and translocation through hematogenous or lymphatic pathways from other body sites.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What differences does the review describe between healthy and diseased breast microbiomes?",{"text":118,"@type":114},"It states that comparative studies show distinct microbial signatures between healthy and diseased tissues, varying further across breast cancer subtypes and compared with adjacent normal tissues.",{"name":120,"@type":111,"acceptedAnswer":121},"Which methodological challenges remain in breast microbiome research?",{"text":122,"@type":114},"Key challenges include low-biomass contamination, inter-study variability, limited longitudinal data, and an incomplete understanding of causality.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363615,1790334051,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \nThe Human Breast Microbiome: From Homeostasis to  \nMalignancy, Mechanistic Insights and Therapeutic Perspectives  \nMysoon M. Al-Ansari 1,2, *, Suha M. Mahmood 1,2 and Monther Al-Alwan 2,3, *  \nAcademic Editor: Andreas Burkovski  \nReceived: 22 April 2026  \nRevised: 21 May 2026  \nAccepted: 21 May 2026  \nPublished: 24 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; [443204671@student.ksu.edu.sa](443204671@student.ksu.edu.sa)  \n2 Innovation and Research, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia  \n3 College of Medicine, Al-Faisal University, Riyadh 11533, Saudi Arabia  \n* [Correspondence: myalansari@ksu.edu.sa](Correspondence: myalansari@ksu.edu.sa) (M.M.A.-A.); [malwan@kfshrc.edu.sa](malwan@kfshrc.edu.sa) (M.A.-A.)  \nAbstract  \nAlthough human mammary glands were traditionally considered sterile, accumulating evidence has established the presence of distinct microbial communities that may have colonized breast tissue primarily via retrograde nipple flow or via hematogenous or lymphatic translocation from other body sites. Comparative studies reveal differences in the microbiota of healthy and diseased breast tissues, with variations in microbial signatures across breast cancer subtypes and in comparison with adjacent normal tissues. This review synthesizes current evidence on the composition of the breast microbiome, the factors shaping its development, and alterations it undergoes in inflammatory and malignant breast diseases. Furthermore, the article discusses mechanistic insights, methodological challenges, and future therapeutic perspectives based on published studies employing culture-independent approaches, such as 16S rRNA gene sequencing and metagenomic analyses. Key host-related factors influencing breast-associated microbial communities, including hormonal regulation, environmental exposure, diet, and therapeutic interventions, are explored. The existing literature is assessed to identify key associations between the breast microbiome and host signaling pathways, as well as the significant challenges that remain unresolved, including low biomass contamination, inter-study variability, limited longitudinal data, and an incomplete understanding of causality. Addressing these limitations is critical for advancing microbiome-based diagnostic and therapeutic strategies for breast disease.  \nKeywords: breast cancer; microbiome; metagenomics; therapy resistance; dysbiosis  \n1. Introduction  \n1.1. The Human Microbiome: A Brief Overview  \nThe microbiome encompasses microbial communities (viruses, bacteria, fungi, and archaea) and their collective genomes that naturally coexist in a given habitat [1] . Recent developments in shotgun metagenomics, an untargeted sequencing method that analyzes the entire DNA content of a sample to determine species-level taxonomic profiles and functional genes without PCR amplification of specific targets, have facilitated the precise characterization of low-biomass breast tissue microbiota. This approach helps distinguish authentic tissue-resident microbes from potential contaminants [2] . The microbiome is essential for vitamin biosynthesis, immune system maturation, xenobiotic metabolism, and maintenance of epithelial barrier integrity [3,4] . Recent multiomics studies have  \nrevealed that host genetics account for only a minor fraction of microbiome variation, with environmental exposure and diet exerting a stronger influence [5] . Multiple factors—such as heredity, environment, and nutrition—influence the diversity of the human microbiome, creating a unique fingerprint for each individual (Figure 1) [6] . Any alteration to the microbiome is a double-edged sword, as it may a","cbCaiogynuNqF9hc","https://ap.wps.com/l/cbCaiogynuNqF9hc","pdf",2719830,21,"English","# Abstract\n# 1. Introduction\n## 1.1. The Human Microbiome: A Brief Overview\n## Figure 1. Schematic summarizing the dynamic seeding and lifelong modulation of the human breast microbiome","[{\"question\":\"How can microbes reach breast tissue according to the review?\",\"answer\":\"The review notes possible routes including retrograde nipple flow and translocation through hematogenous or lymphatic pathways from other body sites.\"},{\"question\":\"What differences does the review describe between healthy and diseased breast microbiomes?\",\"answer\":\"It states that comparative studies show distinct microbial signatures between healthy and diseased tissues, varying further across breast cancer subtypes and compared with adjacent normal tissues.\"},{\"question\":\"Which methodological challenges remain in breast microbiome research?\",\"answer\":\"Key challenges include low-biomass contamination, inter-study variability, limited longitudinal data, and an incomplete understanding of causality.\"}]","The Human Breast Microbiome - From Homeostasis to Malignancy, Mechanistic Insights and Therapeutic Perspectives | PDF",1790152159,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d56230a3eae2e03c641e1f5f09c9fe4.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39cf5574551052f52627457545031804.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5055b7aaf05e926663be21c06e564c3d.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d928e6a3906cb52e6277d47d52feeb2.webp",980,1385]